Roger M. Freidinger
Merck & Co., Inc., Rahway, NJ, USA (United States) · 304 works · 8,174 citations · h-index 45
Top works
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins
- A potent cyclic hexapeptide analogue of somatostatin
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
- Bioactive Conformation of Luteinizing Hormone-Releasing Hormone: Evidence from a Conformationally Constrained Analog
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260
- Synthesis of 9-fluorenylmethyloxycarbonyl-protected N-alkyl amino acids by reduction of oxazolidinones
- Protected lactam-bridged dipeptides for use as conformational constraints in peptides
- A super active cyclic hexapeptide analog of somatostatin
- Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.
- In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia
- Practical synthesis of cyclic peptides, with an example of dependence of cyclization yield upon linear sequence
- A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
- Synthesis and resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones
- Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists
- Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
- The design of metabolically-stable peptide analogs
- A Structurally Unique, Potent, and Selective Oxytocin Antagonist Derived from Streptomyces silvensis
- Design and Synthesis of Novel Bioactive Peptides and Peptidomimetics
- Synthesis, evaluation, and crystallographic analysis of L-371,912: A potent and selective active-site thrombin inhibitor